The North America Chronic Disease Management Market would witness market growth of 11.0% CAGR during the forecast period (2022-2028).
Motivational interviewing and coaching are two well-known methodologies. Cost savings and better outcomes have both been linked to more patient activation and participation. But, it is still unclear whether such a scheme can genuinely lessen the financial burden of rising medical costs for those with chronic conditions.
Since some studies of disease management programmes have examined the influence on health care costs, the body of evidence is fairly thin. Few studies effectively characterize programme components in order to identify which components have an impact on costs. Whereas it is frequently believed that preventative interventions lower net health care costs, this is not always the case.
The Healthcare Navigator, a programme for the treatment of chronic diseases, was developed by the American Health Data Institute (AHDI) in 2002. The Healthcare Navigator programme is a part of an integrated approach to controlling health care utilization, and its goal is to assist client firms in lowering their health care expenditures by enhancing both self-care and the receiving of necessary preventive treatment from formal health care providers.
The US market dominated the North America Chronic Disease Management Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $2,637.9 million by 2028.The Canada market is poised to grow at a CAGR of 13.5% during (2022 - 2028). Additionally, The Mexico market would witness a CAGR of 12.5% during (2022 - 2028).
Based on Type, the market is segmented into Solutions and Services. Based on End User, the market is segmented into Healthcare Providers, Healthcare Payers and Others. Based on Disease Type, the market is segmented into Diabetes, Cardiovascular diseases, Asthma, Chronic obstructive pulmonary disorders, Cancer and Others. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
Free Valuable Insights: The Global Chronic Disease Management Market is Estimated to reach $9.9 Billion by 2028, at a CAGR of 11.7%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Infosys Limited, ExlService Holdings, Inc., Health Catalyst, Inc., AllScripts Healthcare Solutions, Inc., Koninklijke Philips N.V., Cognizant Technology Solutions Corporation, Casenet, LLC, Cedar Gate Technologies, Clinical Excellence, Inc., and Altruista Health, Inc.
By Type
By End User
By Disease Type
By Country
Unique Offerings Our team of dedicated experts can provide you with attractive expansion opportunities for your business.
